Zimmer Biomet Company Top Insiders
ZBH Stock | USD 110.73 1.05 0.94% |
Zimmer Biomet employs about 17 K people. The company is managed by 35 executives with a total tenure of roughly 203 years, averaging almost 5.0 years of service per executive, having 485.71 employees per reported executive. Assessment of Zimmer Biomet's management performance can provide insight into the firm performance.
Larry Glasscock Chairman Independent Non-Executive Chairman of the Board |
Bryan Hanson Chairman Chairman of the Board, President, Chief Executive Officer |
Zimmer |
Zimmer Biomet's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Zimmer Biomet's future performance. Based on our forecasts, it is anticipated that Zimmer will maintain a workforce of under 17000 employees by April 2025.Zimmer Biomet's latest congressional trading
Congressional trading in companies like Zimmer Biomet Holdings, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Zimmer Biomet by those in governmental positions are based on the same information available to the general public.
2025-03-13 | Representative Julie Johnson | Acquired Under $15K | Verify | ||
2024-12-06 | Representative Ro Khanna | Acquired Under $15K | Verify | ||
2017-01-04 | Senator John Reed | Acquired Under $15K | Verify |
Zimmer Biomet Management Team Effectiveness
The company has Return on Asset of 0.0465 % which means that on every $100 spent on assets, it made $0.0465 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0725 %, implying that it generated $0.0725 on every 100 dollars invested. Zimmer Biomet's management efficiency ratios could be used to measure how well Zimmer Biomet manages its routine affairs as well as how well it operates its assets and liabilities. The Zimmer Biomet's current Return On Tangible Assets is estimated to increase to 0.17, while Return On Capital Employed is projected to decrease to 0.06. As of now, Zimmer Biomet's Asset Turnover is decreasing as compared to previous years.Zimmer Biomet Workforce Comparison
Zimmer Biomet Holdings is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 406,293. Zimmer Biomet holds roughly 17,000 in number of employees claiming about 4% of equities under Health Care industry.
Zimmer Biomet Profit Margins
The company has Net Profit Margin of 0.12 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.23 %, which entails that for every 100 dollars of revenue, it generated $0.23 of operating income.Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Gross Profit Margin | 0.8 | 0.7146 |
|
| |||||
Operating Profit Margin | 0.22 | 0.1674 |
|
|
Zimmer Biomet Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Zimmer Biomet insiders, such as employees or executives, is commonly permitted as long as it does not rely on Zimmer Biomet's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Zimmer Biomet insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2025-03-01 | 0.8542 | 41 | 48 | 378,340 | 217,534 |
2024-12-01 | 5.5 | 11 | 2 | 34,148 | 23,045 |
2024-09-01 | 5.0 | 10 | 2 | 4,843 | 3,190 |
2024-06-01 | 6.2 | 31 | 5 | 18,766 | 14,668 |
2024-03-01 | 0.975 | 39 | 40 | 194,901 | 134,290 |
2023-12-01 | 1.0 | 10 | 10 | 4,346 | 54,956 |
2023-09-01 | 6.6667 | 20 | 3 | 31,806 | 8,078 |
2023-06-01 | 15.0 | 30 | 2 | 15,737 | 825.00 |
2023-03-01 | 1.625 | 26 | 16 | 162,668 | 83,458 |
2022-12-01 | 1.8571 | 13 | 7 | 17,129 | 26,399 |
2022-09-01 | 2.5 | 10 | 4 | 6,105 | 8,181 |
2022-06-01 | 15.5 | 31 | 2 | 22,869 | 698.00 |
2022-03-01 | 9.75 | 39 | 4 | 467,147 | 64,913 |
2021-12-01 | 0.4839 | 15 | 31 | 64,115 | 200,119 |
2021-09-01 | 6.0 | 12 | 2 | 55,755 | 4,767 |
2021-06-01 | 10.0 | 30 | 3 | 18,583 | 1,677 |
2021-03-01 | 1.5789 | 30 | 19 | 288,100 | 46,869 |
2020-12-01 | 1.1538 | 15 | 13 | 44,019 | 79,541 |
2020-09-01 | 3.6667 | 11 | 3 | 7,069 | 6,288 |
2020-06-01 | 15.5 | 31 | 2 | 25,622 | 9,717 |
2020-03-01 | 2.3571 | 33 | 14 | 391,443 | 47,148 |
2019-12-01 | 1.1111 | 20 | 18 | 32,522 | 48,096 |
2019-09-01 | 1.8571 | 13 | 7 | 114,086 | 74,745 |
2019-06-01 | 7.5 | 30 | 4 | 25,796 | 11,639 |
2019-03-01 | 3.5385 | 46 | 13 | 365,528 | 22,627 |
2018-12-01 | 8.0 | 16 | 2 | 65,078 | 12,622 |
2018-09-01 | 2.1429 | 15 | 7 | 61,162 | 71,701 |
2018-06-01 | 3.7143 | 26 | 7 | 31,431 | 20,582 |
2018-03-01 | 5.8333 | 35 | 6 | 588,586 | 48,557 |
2017-12-01 | 1.8571 | 13 | 7 | 339,212 | 25,762 |
2017-09-01 | 1.5556 | 14 | 9 | 26,361 | 33,282 |
2017-06-01 | 1.7619 | 37 | 21 | 174,048 | 283,208 |
2017-03-01 | 1.6818 | 37 | 22 | 523,484 | 270,163 |
2016-12-01 | 5.0 | 10 | 2 | 6,975 | 10,100 |
2016-09-01 | 0.9167 | 11 | 12 | 19,968 | 66,618 |
2016-06-01 | 3.0909 | 34 | 11 | 23,585 | 50,622 |
2016-03-01 | 1.5714 | 33 | 21 | 574,565 | 40,720,036 |
2015-12-01 | 2.25 | 9 | 4 | 6,733 | 10,844 |
2015-06-01 | 1.0385 | 54 | 52 | 798,845 | 209,284 |
2015-03-01 | 1.1429 | 24 | 21 | 170,302 | 139,375 |
2014-12-01 | 0.875 | 14 | 16 | 91,430 | 138,016 |
2014-09-01 | 1.6667 | 10 | 6 | 82,642 | 92,473 |
Zimmer Biomet Notable Stakeholders
A Zimmer Biomet stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Zimmer Biomet often face trade-offs trying to please all of them. Zimmer Biomet's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Zimmer Biomet's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Larry Glasscock | Independent Non-Executive Chairman of the Board | Profile | |
Bryan Hanson | Chairman of the Board, President, Chief Executive Officer | Profile | |
Ellison Humphrey | Senior Vice President, Chief Transformation Officer | Profile | |
Derek Davis | Chief Accounting Officer, Vice President, Controller | Profile | |
Ivan Tornos | Group President - Global Businesses and Americas | Profile | |
Suketu Upadhyay | Chief Financial Officer, Executive Vice President | Profile | |
Sang Yi | President Asia Pacific | Profile | |
Chad Phipps | Senior Vice President, General Counsel, Secretary | Profile | |
Arthur Higgins | Independent Director | Profile | |
Michael Michelson | Independent Director | Profile | |
Christopher Begley | Lead Independent Director | Profile | |
Betsy Bernard | Independent Director | Profile | |
Maria Hilado | Independent Director | Profile | |
Syed Jafry | Independent Director | Profile | |
Michael Farrell | Independent Director | Profile | |
Zachary CPA | Director Relations | Profile | |
Gail Boudreaux | Independent Director | Profile | |
Robert Hagemann | Independent Director | Profile | |
Chad JD | General VP | Profile | |
Angela Main | Global VP | Profile | |
Sreelakshmi Kolli | Independent Director | Profile | |
Didier Deltort | President - Europe, Middle East and Africa | Profile | |
Carrie Nichol | Chief Accounting Officer, Vice President Controller | Profile | |
Kenneth Tripp | Senior Logistics | Profile | |
Nitin Goyal | Chief Science, Technology and Innovation Officer | Profile | |
Wilfred Zuilen | President - Europe, Middle East and Africa | Profile | |
Zeeshan Tariq | Senior Officer | Profile | |
Keri Mattox | Senior Vice President - Investor Relations, Chief Communications Officer | Profile | |
Rachel Ellingson | Senior Vice President Chief Strategy Officer, Executive Officer | Profile | |
Kristen Cardillo | Senior Officer | Profile | |
Nitin MD | Technology Science | Profile | |
Paul Stellato | Controller VP | Profile | |
Lori Winkler | Chief Human Resource Officer, Senior Vice President | Profile | |
David DeMartino | Senior Relations | Profile | |
Shaun Braun | Senior Officer | Profile |
About Zimmer Biomet Management Performance
The success or failure of an entity such as Zimmer Biomet Holdings often depends on how effective the management is. Zimmer Biomet management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Zimmer management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Zimmer management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.12 | 0.17 | |
Return On Capital Employed | 0.07 | 0.06 | |
Return On Assets | 0.04 | 0.04 | |
Return On Equity | 0.07 | 0.07 |
Zimmer Biomet Workforce Analysis
Traditionally, organizations such as Zimmer Biomet use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Zimmer Biomet within its industry.Zimmer Biomet Manpower Efficiency
Return on Zimmer Biomet Manpower
Revenue Per Employee | 451.7K | |
Revenue Per Executive | 219.4M | |
Net Income Per Employee | 26.6K | |
Net Income Per Executive | 12.9M | |
Working Capital Per Employee | 130.6K | |
Working Capital Per Executive | 63.4M |
Complementary Tools for Zimmer Stock analysis
When running Zimmer Biomet's price analysis, check to measure Zimmer Biomet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zimmer Biomet is operating at the current time. Most of Zimmer Biomet's value examination focuses on studying past and present price action to predict the probability of Zimmer Biomet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zimmer Biomet's price. Additionally, you may evaluate how the addition of Zimmer Biomet to your portfolios can decrease your overall portfolio volatility.
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |